Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CL

Colgate-Palmolive Raises Dividend By 4.4%, Approves New $5B Share Buyback

Colgate-Palmolive Company (NYSE:CL) declared a quarterly common stock cash dividend of $0.47 per share, an increase from the prior dividend of $0.45. The dividend is payable on May 13, 2022, to shareholders of record on April 21, 2022. The Board also authorized up to $5 billion repurchase of the Company's common stock.…

Buy These 5 Defensive Stocks to Protect Your Portfolio from Market Volatility

Buy These 5 Defensive Stocks to Protect Your Portfolio from Market Volatility

Defensive stocks are known for exhibiting stability during wild price swings in the market. And growing sanctions on Russia and the unstable nature of crude oil prices may drive further volatility in the market. So, we think it could be wise to bet now on defensive stocks CVS Health (CVS),…

Take Advantage of the Dip and Buy These 3 Dividend Aristocrats in the Consumer Staples Sector

Take Advantage of the Dip and Buy These 3 Dividend Aristocrats in the Consumer Staples Sector

The Russia-Ukraine war has led to heightened volatility in the stock market. The consumer staples sector faces a persistent demand, making them decline less during bear markets. Therefore, it could be worth buying the dip in consistent dividend-paying stocks in the consumer staples sector Colgate-Palmolive (CL), Sysco Corporation (SYY), and…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Cannabis Stocks Chart: EBITDA Estimate Revisions – It's All About The Margins

Several market commentators have recently noted that the consensus analyst revenue estimates for the large MSOs have declined by low single-digit percentages since November.

4 Dividend Aristocrats to Buy in February

Rising inflation and the Fed’s signal that it will raise interest rates multiple times this year fostered high market volatility last month. And although the major market indexes rose for the third consecutive trading session yesterday, many analysts expect the market to remain volatile this year. Given this backdrop, we…

Credit Suisse Cuts Price Target On This Consumer Goods Giant- Read Why

Credit Suisse analyst Kaumil Gajrawala lowered the price target of Colgate-Palmolive Co (NYSE: CL) to $90 from $95 and kept an Outperform rating on the shares, implying a 9.3% upside.

4 Consumer Defensive Stocks Bucking the Market's Downward Trend

The Fed’s decision to raise interest rates, a disappointing employment report, rising inflation, and persistent supply chain disruptions will likely continue spooking investors. So, in this environment, we think consumer defensive stocks Coca-Cola (KO), Colgate (CL), General Mills (GIS), and Hershey (HSY), which typically perform with aplomb during periods of…

inkl

Read news from The Economist, FT, and more,
with one subscription

Colgate-Palmolive Partners With 3Shape To Help Patients Visualize Teeth Whitening Product

Colgate-Palmolive Partners With 3Shape To Help Patients Visualize Teeth Whitening Product

Colgate-Palmolive Co (NYSE:CL) has partnered with 3Shape to launch Colgate Illuminator, a tailored-to-patient teeth whitening tool, to dental clinics across the U.S. The financial terms were not disclosed. 3Shape is a digital dentistry 3D scanner software and service provider. The new in-clinic predictive tool will show personalized results for consumers of Colgate's teeth whitening…

Jake Humphrey slammed over ‘embarrassing’ Thomas Tuchel and Frank Lampard comparison

Jake Humphrey slammed over ‘embarrassing’ Thomas Tuchel and Frank Lampard comparison

Chelsea have fallen off a cliff in terms of form over the past two months and have gone from Premier League title challengers to potentially dropping out of the top four

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Johnson & Johnson (

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

314,349 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play